Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orgad

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
Stroke|December 22, 2025
Early Detection of Large Vessel Occlusions by Bilateral Carotid Pressure Monitoring: Blinded Observational StudyHilla Ben-Pazi, Lior Elmalich, Yair Lavi, et al.
International Journal of Cancer|October 10, 2022
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriersKeren Bahar-Shany, Georgina D Barnabas, Lisa Deutsch, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
Stroke|December 22, 2025
Early Detection of Large Vessel Occlusions by Bilateral Carotid Pressure Monitoring: Blinded Observational StudyHilla Ben-Pazi, Lior Elmalich, Yair Lavi, et al.
International Journal of Cancer|October 10, 2022
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriersKeren Bahar-Shany, Georgina D Barnabas, Lisa Deutsch, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Pageof 15